Study on Indomethacin-responsive Headaches
Overview
Description of modalities concerning the patient care of headaches sensible to indometacine.
Full Title of Study: “Non Interventional Study on Indomethacin-responsive Headaches”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: June 1, 2020
Detailed Description
Description of clinical profile, treatment of crisis and background treatment
Interventions
- Drug: Indometacin
- patient who are taken indomatacin for headaches and migraine
Clinical Trial Outcome Measures
Primary Measures
- Description of headaches sensible to indometacine
- Time Frame: 24 monthes
- Description of the clinical cases with headaches sensible to indometacine according to the type of headaches.
Participating in This Clinical Trial
Inclusion Criteria
- patient with a diagnosis of migraine with or without aura, or trigemino-autosomic headaches or other primary headaches – patient who are taking indometacine – patient with written consent form Exclusion Criteria:
- patient under 18 years – pregnant woman or breastfeeding patient – patient who refuses to participate
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 100 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Anne Ducros
- Provider of Information About this Clinical Study
- Sponsor-Investigator: Anne Ducros, Pr – French Society for the Study of Migraine Headache
- Overall Contact(s)
- Anne DONNET, 0491384340, Anne.DONNET@ap-hm.fr
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.